Mackenzie Financial Corp Purchases 52,441 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Mackenzie Financial Corp increased its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 22.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 289,870 shares of the real estate investment trust's stock after acquiring an additional 52,441 shares during the period. Mackenzie Financial Corp owned about 0.12% of Sabra Health Care REIT worth $5,021,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of SBRA. Barclays PLC increased its stake in shares of Sabra Health Care REIT by 56.1% in the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock worth $12,624,000 after purchasing an additional 243,895 shares during the period. Bank of New York Mellon Corp increased its stake in Sabra Health Care REIT by 13.0% during the fourth quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock valued at $69,967,000 after acquiring an additional 463,601 shares during the period. Jefferies Financial Group Inc. bought a new position in Sabra Health Care REIT during the fourth quarter valued at about $348,000. abrdn plc increased its stake in Sabra Health Care REIT by 2.9% during the fourth quarter. abrdn plc now owns 900,690 shares of the real estate investment trust's stock valued at $15,600,000 after acquiring an additional 25,195 shares during the period. Finally, ExodusPoint Capital Management LP increased its stake in Sabra Health Care REIT by 66.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 917,166 shares of the real estate investment trust's stock valued at $15,885,000 after acquiring an additional 367,777 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Health Care REIT Price Performance

NASDAQ:SBRA remained flat at $17.48 during trading hours on Monday. The company's stock had a trading volume of 1,572,883 shares, compared to its average volume of 2,219,526. The company's fifty day moving average is $17.54 and its 200 day moving average is $17.31. Sabra Health Care REIT, Inc. has a 12-month low of $13.87 and a 12-month high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The firm has a market capitalization of $4.16 billion, a P/E ratio of 32.98, a P/E/G ratio of 1.97 and a beta of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.01. The firm had revenue of $183.54 million for the quarter, compared to the consensus estimate of $180.23 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The business's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.35 EPS. On average, equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.86%. The ex-dividend date was Friday, May 16th. Sabra Health Care REIT's payout ratio is 203.39%.

Insider Activity at Sabra Health Care REIT

In related news, Director Michael J. Foster sold 11,000 shares of the company's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the sale, the director now owns 64,725 shares in the company, valued at $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Scotiabank boosted their price target on Sabra Health Care REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a research note on Monday, May 12th. Truist Financial boosted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.